Gabelli & Co Investment Advisers’s Array Biopharma Inc ARRY Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-543,580	Closed	-$25.2M	–	219
2019 Q2	$25.2M	Buy	+543,580	New	+$15.3M	2.7%	13

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Gabelli & Co Investment Advisers's ARRY Position: Q3 2019 in Review

Gabelli & Co Investment Advisers sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 543,580 shares — an estimated $25.2M sold.

Gabelli & Co Investment Advisers first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $25.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Gabelli & Co Investment Advisers reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 543,580 Array Biopharma Inc shares in Q3 2019, an estimated $25.2M.
Gabelli & Co Investment Advisers first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Array Biopharma Inc position peaked at $25.2M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2019, filed 1 Nov 2019.